NO20003220D0 - Farmasøytiske preparater innbefattende miceller omfattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel - Google Patents

Farmasøytiske preparater innbefattende miceller omfattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel

Info

Publication number
NO20003220D0
NO20003220D0 NO20003220A NO20003220A NO20003220D0 NO 20003220 D0 NO20003220 D0 NO 20003220D0 NO 20003220 A NO20003220 A NO 20003220A NO 20003220 A NO20003220 A NO 20003220A NO 20003220 D0 NO20003220 D0 NO 20003220D0
Authority
NO
Norway
Prior art keywords
surfactant
pharmaceutical preparations
preparations including
including micelles
lipophilic glucocorticosteroid
Prior art date
Application number
NO20003220A
Other languages
English (en)
Other versions
NO20003220L (no
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20003220D0 publication Critical patent/NO20003220D0/no
Publication of NO20003220L publication Critical patent/NO20003220L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003220A 1997-12-22 2000-06-21 Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel NO20003220L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (2)

Publication Number Publication Date
NO20003220D0 true NO20003220D0 (no) 2000-06-21
NO20003220L NO20003220L (no) 2000-08-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003220A NO20003220L (no) 1997-12-22 2000-06-21 Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel

Country Status (20)

Country Link
EP (1) EP1043973A1 (no)
JP (1) JP2001526210A (no)
KR (1) KR20010024789A (no)
CN (1) CN1283106A (no)
AR (1) AR017220A1 (no)
AU (1) AU1993599A (no)
BR (1) BR9813811A (no)
CA (1) CA2315782A1 (no)
EE (1) EE200000388A (no)
HU (1) HUP0102365A3 (no)
ID (1) ID26945A (no)
IL (1) IL136880A0 (no)
NO (1) NO20003220L (no)
NZ (1) NZ505073A (no)
PL (1) PL341361A1 (no)
SE (1) SE9704833D0 (no)
SK (1) SK9532000A3 (no)
TR (1) TR200001977T2 (no)
WO (1) WO1999032089A1 (no)
ZA (1) ZA9811461B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
JP4436041B2 (ja) 2000-08-05 2010-03-24 グラクソ グループ リミテッド 抗炎症剤としての６α，９α−ジフルオロ−１７α−［（２−フラニルカルボキシル）オキシ］−１１β−ヒドロキシ−１６α−メチル−３−オキソ−アンドロスト−１，４−ジエン−１７−チオカルボン酸Ｓ−フルオロメチルエステル
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
BR0209271A (pt) 2001-04-30 2004-06-15 Glaxo Group Ltd Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
DK2211896T3 (en) 2007-11-13 2018-03-12 Meritage Pharma Inc COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATION
US8865692B2 (en) 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
RU2519193C2 (ru) * 2008-09-12 2014-06-10 Критикал Фармасьютикалс Лимитед Усовершенствование всасывания терапевтических средств через слизистые оболочки или кожу
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.

Also Published As

Publication number Publication date
CN1283106A (zh) 2001-02-07
AR017220A1 (es) 2001-08-22
HUP0102365A2 (hu) 2001-11-28
SE9704833D0 (sv) 1997-12-22
SK9532000A3 (en) 2000-11-07
NZ505073A (en) 2002-09-27
ID26945A (id) 2001-02-22
JP2001526210A (ja) 2001-12-18
BR9813811A (pt) 2000-10-03
IL136880A0 (en) 2001-06-14
TR200001977T2 (tr) 2000-12-21
PL341361A1 (en) 2001-04-09
EP1043973A1 (en) 2000-10-18
CA2315782A1 (en) 1999-07-01
EE200000388A (et) 2002-02-15
ZA9811461B (en) 1999-06-22
WO1999032089A1 (en) 1999-07-01
NO20003220L (no) 2000-08-22
KR20010024789A (ko) 2001-03-26
AU1993599A (en) 1999-07-12
HUP0102365A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
NO20003220L (no) Farmasøytiske preparater omfattende miceller innbefattende lipofilt glukokortikosteroid og kun ett overflateaktivt middel
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK1015596T4 (da) Fusionsproteiner omfattende HIV-1 Tat- og/eller Nef-proteiner
NO20014220L (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
FI954204A7 (fi) Ruiskeena annettavat liposomilääkevalmisteet
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
DE69831486D1 (de) Antiproliferative zubereitungen
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
HUT77235A (hu) Dermálisan alkalmazható parazita elleni készítmények, és ezek előállítása
DK1071407T3 (da) Lipofile mikropartikler indeholdende et proteinlægemiddel eller et antigen og formulering omhandlende samme
EE200200038A (et) Konservitud farmatseutilised preparaadid
NO993315D0 (no) Raskt frigjörende og smaksmaskerende farmasöytisk doseringsform
NO20011157D0 (no) Benzenderivater og farmasøytisk anvendelse derav
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20025158L (no) Lipidpreparat og anvendelse derav
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
DE69926012D1 (de) Arzneizubereitungen
NO994619L (no) Farmasöytiske blandinger
NO20003141D0 (no) Farmasøytiske blandinger
DE69906934D1 (de) Arzneizubereitungen
EP1142589A4 (en) Medicinal preparations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application